The 2016 edition of MSAA’s MS Research Update provides a comprehensive overview of research findings on many experimental drugs currently under investigation for the long-term treatment of multiple sclerosis. Also included are new clinical trial data on some of the currently approved disease-modifying therapies, as well as directions for future research in areas such as stem-cell research, biomarkers, genetic studies, and gut microbiota.

In addition to the exciting research aimed at relapsing forms of MS, several studies are also looking into the treatment of progressive forms of MS. To assist individuals interested in learning more, trials with progressive forms of MS have been highlighted in bold for quick identification.

This year’s MS Research Update has been published jointly by the Multiple Sclerosis Association of America (MSAA), the Consortium of Multiple Sclerosis Centers (CMSC), and the International Organization of MS Nurses (IOMSN). MSAA greatly appreciates the support from the CMSC and IOMSN to assist with the production of this publication.

Read MSAA’s latest MS Research Update here